Sales 2024 * | 48.15B 45.2B | Sales 2025 * | 49.87B 46.82B | Capitalization | 206B 193B |
---|---|---|---|---|---|
Net income 2024 * | 10.62B 9.97B | Net income 2025 * | 11.58B 10.87B | EV / Sales 2024 * | 4.53 x |
Net Debt 2024 * | 11.85B 11.12B | Net Debt 2025 * | 10.14B 9.52B | EV / Sales 2025 * | 4.34 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
16.4
x | Employees | 76,057 |
Yield 2024 * |
3.89% | Yield 2025 * |
4.02% | Free-Float | 81.95% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
-9.69% | 147B | |
-6.63% | 144B | |
-3.20% | 116B |